David P Meeker

Director; Director, President and CEO · 4 filings · Latest: Jun 17, 2026

Kardigan, Inc.

RHYTHM PHARMACEUTICALS, INC.

Trevi Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
RYTM	David P Meeker	Director, President and CEO	Feb 1, 2026	Option Exercise	—	68,713	—	270,538	Feb 3 9:34 PM
RYTM	DAVID MEEKER	—	Jun 3, 2025	Proposed Sale	$63.66	43,621	$2.8M	—	Jun 3 8:27 PM
TRVI	Meeker David P	—	Aug 27, 2024	Proposed Sale	$2.98	4,555	$13.6K	—	Aug 27 8:10 PM